# ARROWHEAD PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:02360f2d-a681-4f24-b6c0-f5382664fcde | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/arrowhead-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 29 | | Claims under review | 1 | | Evidence records | 8 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-21T04:45:36.70836+00:00 | | Last reviewed | 2026-10-21T04:45:36.70836+00:00 | ## Identity - Legal name: ARROWHEAD PHARMACEUTICALS, INC. - Display name: ARROWHEAD PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-21T04:45:36.70836+00:00 | | Completeness | 0.409 | | Record Quality | 0.828 | | Directors | 6 | | Committees | 7 | | Governance events | 19 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Adeoye Olukotun: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:6 - Christopher Anzalone, PhD: Director. Status: current. Independent: false. Since: 2007-01-01. claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:7 - Hongbo Lu, PhD: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:8 - Mauro Ferrari, PhD: Director. Status: current. Independent: true. Since: 2010-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:9 - Victoria Vakiener: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:10 - William Waddill: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (chair); Audit · Chair; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:11 ## Committees - Audit (audit). Chair: William Waddill. Members: William Waddill (chair, current); Mauro Ferrari, PhD (member, current); Victoria Vakiener (member, current). committee_id=alpha:committee:arrowhead-pharmaceuticals-inc:audit - Audit · Chair; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: William Waddill (member, current). committee_id=alpha:committee:arrowhead-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Mauro Ferrari, PhD (member, current). committee_id=alpha:committee:arrowhead-pharmaceuticals-inc:audit-nominating-and-governance - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Victoria Vakiener (member, current). committee_id=alpha:committee:arrowhead-pharmaceuticals-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Hongbo Lu, PhD (member, current); William Waddill (member, current). committee_id=alpha:committee:arrowhead-pharmaceuticals-inc:compensation - Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Hongbo Lu, PhD (member, current). committee_id=alpha:committee:arrowhead-pharmaceuticals-inc:compensation-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: Victoria Vakiener. Members: Victoria Vakiener (chair, current); Adeoye Olukotun (member, current); Hongbo Lu, PhD (member, current); Mauro Ferrari, PhD (member, current); William Waddill (member, current). committee_id=alpha:committee:arrowhead-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Christopher Anzalone: Chief Executive Officer, President, Director and Board Chair [CEO]. Status: current. claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:12 - Daniel Apel: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:13 - James Hamilton: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:14 - Patrick C. O'Brien: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:15 - Vincent Anzalone: Senior Vice President, Investor Relations and Corporate Communications. Status: unknown. claim_id=alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:16 ## Governance events - CEO_CHANGED: Christopher Anzalone executive of ARROWHEAD PHARMACEUTICALS, INC., effective 2026-01-27. Effective: 2026-01-27. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:hmy1931d9u54l - CFO_CHANGED: Daniel Apel executive of ARROWHEAD PHARMACEUTICALS, INC., effective 2026-01-27. Effective: 2026-01-27. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1fu730fg4xhm - EXECUTIVE_APPOINTED: James Hamilton executive of ARROWHEAD PHARMACEUTICALS, INC., effective 2026-01-27. Effective: 2026-01-27. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:xde4dd1ytvkvt - EXECUTIVE_APPOINTED: Patrick C. O'Brien executive of ARROWHEAD PHARMACEUTICALS, INC., effective 2026-01-27. Effective: 2026-01-27. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:g57p0s1ep11li - DIRECTOR_APPOINTED: Hongbo Lu, PhD seat on ARROWHEAD PHARMACEUTICALS, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:42ixns1wezrfa - COMMITTEE_CREATED: Compensation; Nominating and Governance committee of ARROWHEAD PHARMACEUTICALS, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1wrtdl01cjp9hi - COMMITTEE_MEMBER_ADDED: Hongbo Lu, PhD member of Compensation; Nominating and Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1j6t521zs4ec1 - DIRECTOR_APPOINTED: Victoria Vakiener seat on ARROWHEAD PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1ci8jbt1q3tilh - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of ARROWHEAD PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:cfcq9d1x31xnh - COMMITTEE_MEMBER_ADDED: Victoria Vakiener member of Audit; Nominating and Governance · Chair, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:10rxrxzpnrtj - DIRECTOR_APPOINTED: Adeoye Olukotun seat on ARROWHEAD PHARMACEUTICALS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:17zbh1s76wjrs - COMMITTEE_MEMBER_ADDED: Adeoye Olukotun member of Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1i4s9u4mvk3t6 - DIRECTOR_APPOINTED: William Waddill seat on ARROWHEAD PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:8qbqlv1tmp0ld - COMMITTEE_CREATED: Audit · Chair; Compensation; Nominating and Governance committee of ARROWHEAD PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:ijl94924719p - COMMITTEE_MEMBER_ADDED: William Waddill member of Audit · Chair; Compensation; Nominating and Governance, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1q49f6ynvzch6 - DIRECTOR_APPOINTED: Mauro Ferrari, PhD seat on ARROWHEAD PHARMACEUTICALS, INC., effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:t043aq1jzdmmw - COMMITTEE_CREATED: Audit; Nominating and Governance committee of ARROWHEAD PHARMACEUTICALS, INC., effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:bmzyj818vi7uc - COMMITTEE_MEMBER_ADDED: Mauro Ferrari, PhD member of Audit; Nominating and Governance, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1ebr6kat56vvi - DIRECTOR_APPOINTED: Christopher Anzalone, PhD seat on ARROWHEAD PHARMACEUTICALS, INC., effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-21T04:45:36.70836+00:00. event_id=alpha:event:transition:1ca1abo1ma0tdg ## Scoped resources - `alpha://company/arrowhead-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record - `alpha://company/arrowhead-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/arrowhead-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/arrowhead-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=board - `alpha://company/arrowhead-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/arrowhead-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/arrowhead-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/arrowhead-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/arrowhead-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/arrowhead-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/arrowhead-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/arrowhead-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/arrowhead-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/arrowhead-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/arrowhead-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/arrowhead-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/arrowhead-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/arrowhead-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/arrowhead-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/arrowhead-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=events - `alpha://company/arrowhead-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/arrowhead-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/arrowhead-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:william-waddill","name":"William Waddill"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mauro-ferrari-phd","name":"Mauro Ferrari, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:victoria-vakiener","name":"Victoria Vakiener"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:hongbo-lu-phd","name":"Hongbo Lu, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:william-waddill","name":"William Waddill"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:victoria-vakiener","name":"Victoria Vakiener"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:adeoye-olukotun","name":"Adeoye Olukotun"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:hongbo-lu-phd","name":"Hongbo Lu, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:mauro-ferrari-phd","name":"Mauro Ferrari, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:william-waddill","name":"William Waddill"},"source_id":"board_seats"}` ## Leadership - Adeoye Olukotun: Director, Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ba10ea7cd5c0ce04ec0609adac7acbc54324be0fa6f6dfbdecc6d1f2a328f0d0. - Christopher Anzalone, PhD: Director. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:7. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ba10ea7cd5c0ce04ec0609adac7acbc54324be0fa6f6dfbdecc6d1f2a328f0d0. - Hongbo Lu, PhD: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ba10ea7cd5c0ce04ec0609adac7acbc54324be0fa6f6dfbdecc6d1f2a328f0d0. - Mauro Ferrari, PhD: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:9. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ba10ea7cd5c0ce04ec0609adac7acbc54324be0fa6f6dfbdecc6d1f2a328f0d0. - Victoria Vakiener: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:10. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ba10ea7cd5c0ce04ec0609adac7acbc54324be0fa6f6dfbdecc6d1f2a328f0d0. - William Waddill: Director, Audit · Chair; Compensation; Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:11. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ba10ea7cd5c0ce04ec0609adac7acbc54324be0fa6f6dfbdecc6d1f2a328f0d0. - Christopher Anzalone: Chief Executive Officer, President, Director and Board Chair. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:12. Valid from: 2026-01-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:28846246768d2e19362b08e4517fb99eff463c17d9585aa54d87715aebbc3844. - Daniel Apel: Chief Financial Officer. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:13. Valid from: 2026-01-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b6bb21956d91fecb2702cd7c6a3ba257a1be0668d3dadf3f3348530f97cf743c. - James Hamilton: Chief Medical Officer. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:14. Valid from: 2026-01-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:863f673847990ae9bf8c26945d98792bc976751c95cc88bfed5c74e19095e802. - Patrick C. O'Brien: Chief Operating Officer. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:15. Valid from: 2026-01-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d07ee688c0892996dc7bd47066e503011f32e3dc96d916a3b2e52e450888173c. - Vincent Anzalone: Senior Vice President, Investor Relations and Corporate Communications. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3e7ad3a2e653b93c3b78d8084b7d5d3a7e05220780375512f48074cc5377ced. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair William Waddill; Members William Waddill (Chair); Mauro Ferrari, PhD; Victoria Vakiener. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Compensation: Chair not stated; Members Hongbo Lu, PhD; William Waddill. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Nominating and Governance: Chair Victoria Vakiener; Members Victoria Vakiener (Chair); Adeoye Olukotun; Hongbo Lu, PhD; Mauro Ferrari, PhD; William Waddill. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ARROWHEAD PHARMACEUTICALS, INC.. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:177cf47acc7d7b1d02f9f6044c9f200313435d644f86f5a4f13fe334065f9d7d. ## Entity Status - Public listing published. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:177cf47acc7d7b1d02f9f6044c9f200313435d644f86f5a4f13fe334065f9d7d. ## Published Fact - US. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:177cf47acc7d7b1d02f9f6044c9f200313435d644f86f5a4f13fe334065f9d7d. - Healthcare. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:177cf47acc7d7b1d02f9f6044c9f200313435d644f86f5a4f13fe334065f9d7d. ## Committee Appointment - William Waddill: chair, Audit. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Mauro Ferrari, PhD: member, Audit. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Victoria Vakiener: member, Audit. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Hongbo Lu, PhD: member, Compensation. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - William Waddill: member, Compensation. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Victoria Vakiener: chair, Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Adeoye Olukotun: member, Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Hongbo Lu, PhD: member, Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - Mauro Ferrari, PhD: member, Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. - William Waddill: member, Nominating and Governance. Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea. ## Security Listing - ARWR (NASDAQ). Claim: alpha:claim:company:02360f2d-a681-4f24-b6c0-f5382664fcde:security_listing:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:177cf47acc7d7b1d02f9f6044c9f200313435d644f86f5a4f13fe334065f9d7d. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:177cf47acc7d7b1d02f9f6044c9f200313435d644f86f5a4f13fe334065f9d7d: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc). - alpha:projection-evidence:document:ba10ea7cd5c0ce04ec0609adac7acbc54324be0fa6f6dfbdecc6d1f2a328f0d0: [Arrowhead Pharmaceuticals DEF 14A 2026-01-27](https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm). - alpha:projection-evidence:document:28846246768d2e19362b08e4517fb99eff463c17d9585aa54d87715aebbc3844: [ARWR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm). - alpha:projection-evidence:document:b6bb21956d91fecb2702cd7c6a3ba257a1be0668d3dadf3f3348530f97cf743c: [ARWR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm). - alpha:projection-evidence:document:863f673847990ae9bf8c26945d98792bc976751c95cc88bfed5c74e19095e802: [ARWR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm). - alpha:projection-evidence:document:d07ee688c0892996dc7bd47066e503011f32e3dc96d916a3b2e52e450888173c: [ARWR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm). - alpha:projection-evidence:document:f3e7ad3a2e653b93c3b78d8084b7d5d3a7e05220780375512f48074cc5377ced: ARWR executive roster source. - alpha:projection-evidence:eab10a86f02783da5df45e9e63049381849b33bdee1438d03585d97aecd438ea: [Audit](https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/arrowhead-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/arrowhead-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/arrowhead-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/arrowhead-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-21T09:39:06.096149+00:00; recorded 2026-10-21T09:39:06.096149+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.